Christy Harris, PharmD, BCOP, FHOPA
Associate Professor of Pharmacy Practice
School
School of Pharmacy
Department
Pharmacy Practice
Office Location
White 348
Boston
Office Phone Office Phone: 617.879.5909
About
Christy S. Harris is an Associate Professor of Pharmacy Practice at MCPHS Boston with a practice site at the Dana-Farber Cancer Institute. Dr. Harris is a graduate of the University of Tennessee, where she received her Bachelor of Science and Doctor of Pharmacy degrees. She completed 2 years of residency specializing in oncology, is board certified as a specialist in oncology pharmacy, and is a Fellow of the Hematology Oncology Pharmacists Association. She currently works with patients with soft tissue and bone sarcomas. Other interests in her practice include early-phase clinical trials, the adolescent and young adult population, and integrative therapy in cancer.
Education
- BS - University of Tennessee, Martin
- PharmD - University of Tennessee Health Sciences Center, Memphis PGY1 - University of Tennessee Medical Center, Knoxville
- PGY2 Oncology - Medical University of South Carolina, Charleston
- Board Certified Oncology Pharmacist
Research Interests
- Adverse effects associated with anticancer therapy Supportive care in Oncology
- Early phase clinical trials
- Integrative therapies in cancer treatment
Featured Affiliations
American Association of Colleges of Pharmacy (AACP)
LinkAmerican College of Clinical Pharmacy (ACCP)
LinkHematology/Oncology PRN Children's Oncology Group (COG)
LinkEducation
- BS - University of Tennessee, Martin
- PharmD - University of Tennessee Health Sciences Center, Memphis PGY1 - University of Tennessee Medical Center, Knoxville
- PGY2 Oncology - Medical University of South Carolina, Charleston
- Board Certified Oncology Pharmacist
Research Interests
- Adverse effects associated with anticancer therapy Supportive care in Oncology
- Early phase clinical trials
- Integrative therapies in cancer treatment
Publications
- Boyce EG, Harris CS, Bingham AL, et al. Striving for excellence in experiential education. J Amer Coll Clin Pharm 2020;3(3):678-91. https://doi.org/10.1002/jac5.1240
- Engle JP, Burke JM, Ashjian EJ, et al. ACCP clinical pharmacist competencies: Advocating alignment between student, resident, and practitioner competencies. J Amer Coll Clin Pharm 2020;3(1):124-32. https://doi.org/10.1002/jac5.1200
- Holle LM, Harris CS, Chan A, Fahrenbruch RJ, Labdi BA, Mohs JE, Norris LB, Perkins J, Vela CM. Pharmacists’ roles in oncology pharmacy services: Results of a global survey. J Oncol Pharm Pract 2016;23(3):185-94. DOI: 10.1177/1078155216629827
- Szabatura AH, Cirrone F, Harris CS, McDonnell AM, Feng, Y, Voit D, Neuberg D, Butrynski J, Fisher DC. An assessment of risk factors associated with ifosfamide-induced encephalopathy in a large academic cancer center. J Oncol Pharm Pract 2015:21:188-93. DOI: 10.1177/1078155214527143
Memberships/Affiliations
- Hematology Oncology Pharmacy Association (HOPA)
- International Society of Oncology Pharmacy Practitioners (ISOPP)